PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Eluxadoline→

Eluxadoline PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
864821-90-9
PubChem CID
11250029
Molecular formula
C32H35N5O5
Molecular weight
569.6 g/mol
Drug class
mu-Opioid Receptor Agonist
Mechanism of action
Opioid mu-Receptor Agonists
Indications / reported uses
  • Irritable Bowel Syndrome

Identification source: PubChem record (CID 11250029). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Eluxadoline PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Eluxadoline Permitted Daily Exposure (PDE) report (the Eluxadoline PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Eluxadoline Occupational Exposure Limit (OEL) report (the Eluxadoline OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.